文献速递肝病

严重胆汁淤积预测肝移植后原发性硬化性胆管炎复发

Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation.
PubMed 文献 · Am J Gastroenterol · 2024-07-25

该回顾性队列分析纳入加拿大158例和英国549例因原发性硬化性胆管炎(PSC)行肝移植的受者,评估移植后12个月内血清肝生化指标变化与复发性PSC(rPSC)及移植物丢失的关系。结果显示,移植后3-12个月出现严重胆汁淤积与rPSC及移植物丢失相关。

要点

  • 加拿大队列移植后3个月严重胆汁淤积者rPSC发生率20.5% vs 无rPSC者8.2%(P=0.011)。
  • 加拿大队列3个月严重胆汁淤积预测移植物丢失(HR=3.88,P=0.0001)。
  • 英国队列12个月严重胆汁淤积与rPSC相关(HR=3.141,P<0.0001)。

核心结论

  • 肝移植后3-12个月内出现胆汁淤积可预测复发性原发性硬化性胆管炎和移植物丢失。

研究设计与样本

  • 回顾性队列分析,纳入加拿大158例和英国549例因PSC行肝移植的受者。
  • 评估肝移植后12个月内血清肝生化指标,以Cox回归分析胆管造影诊断的rPSC作为时间依赖协变量。
  • 严重胆汁淤积定义为碱性磷酸酶>3倍正常上限或总胆红素>100 μmol/L。

主要发现

  • 加拿大队列中,发生rPSC者 vs 未发生者在3个月时严重胆汁淤积比例为20.5% vs 8.2%(P=0.011),6个月时为17.9% vs 10.0%(P=0.026),12个月时为15.4% vs 7.8%(P=0.051)。
  • 英国队列中,发生rPSC者 vs 未发生者在12个月时严重胆汁淤积比例为27.9% vs 12.6%(P<0.0001)。
  • 多变量分析显示,加拿大队列3个月时严重胆汁淤积与rPSC相关(HR=2.41,P=0.046),英国队列12个月时严重胆汁淤积与rPSC相关(HR=3.141,P<0.0001)。
  • 加拿大队列3个月时严重胆汁淤积可预测移植物丢失(HR=3.88,P=0.0001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Primary sclerosing cholangitis (PSC) may reoccur following liver transplantation (LT), and the diagnosis established once imaging studies demonstrate the diagnostic cholangiographic appearance. To evaluate whether the development of recurrent PSC (rPSC) is associated with cholestasis soon after LT, we studied whether changes in hepatic biochemistry within the first 12 months were linked with the development of rPSC and graft loss. METHODS: We conducted a retrospective cohort analysis of 158 transplant recipients with PSC in Canada and 549 PSC transplant recipients from the United Kingdom. We evaluated serum liver tests within 12 months after LT and the subsequent development of a cholangiographic diagnosis of rPSC as a time-dependent covariate using Cox regression. Severe cholestasis was defined as either alkaline phosphatase > 3× upper limit of normal or total bilirubin > 100 μmol/L. RESULTS: Patients who developed rPSC were more likely to have severe cholestasis vs those without at 3 months (20.5% vs 8.2%, P = 0.011), at 6 months (17.9% vs 10.0%, P = 0.026), and 12 months (15.4% vs 7.8%, P = 0.051) in the Canadian cohort and at 12 months in the UK cohort (27.9% vs 12.6%, P < 0.0001). By multivariable analysis, development of severe cholestasis in the Canadian cohort at 3 months (hazard ratio [HR] = 2.41, P = 0.046) and in the UK cohort at 12 months (HR = 3.141, P < 0.0001) was both associated with rPSC. Severe cholestasis at 3 months in the Canadian cohort was predictive of graft loss (HR = 3.88, P = 0.0001). DISCUSSION: The development of cholestasis within 3-12 months following LT was predictive of rPSC and graft loss.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Aziz B, Kok B, Cheah M, et al. Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation. Am J Gastroenterol. 2024. PMID: 39888688. doi:10.14309/ajg.0000000000002977

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。